AlloVir Inc (ALVR)
0.8164
+0.03
(+4.43%)
USD |
NASDAQ |
May 09, 16:00
0.8162
0.00 (0.00%)
Pre-Market: 20:00
AlloVir Total Assets (Quarterly): 190.80M for Dec. 31, 2023
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 190.80M |
| September 30, 2023 | 248.31M |
| June 30, 2023 | 282.69M |
| March 31, 2023 | 244.04M |
| December 31, 2022 | 277.08M |
| September 30, 2022 | 293.70M |
| June 30, 2022 | 200.00M |
| March 31, 2022 | 231.09M |
| December 31, 2021 | 286.59M |
| Date | Value |
|---|---|
| September 30, 2021 | 316.53M |
| June 30, 2021 | 327.51M |
| March 31, 2021 | 351.28M |
| December 31, 2020 | 370.82M |
| September 30, 2020 | 393.71M |
| June 30, 2020 | 117.85M |
| March 31, 2020 | 128.69M |
| December 31, 2019 | 139.42M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
117.85M
Minimum
Jun 2020
393.71M
Maximum
Sep 2020
258.83M
Average
277.08M
Median
Dec 2022
Total Assets (Quarterly) Benchmarks
| CEL-SCI Corp | 28.71M |
| AIM ImmunoTech Inc | 19.38M |
| IGC Pharma Inc | 11.26M |
| NovaBay Pharmaceuticals Inc | 9.034M |
| Protalix BioTherapeutics Inc | 84.43M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 45.02M |
| Shareholders Equity (Quarterly) | 145.78M |